Oxidative stress serves as a key checkpoint for IL-33 release by airway epithelium

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 72, Issue 10, 2017, Pages 1521-1531

  Uchida, M ^a,b   Anderson, E L ^c   Squillace, D L ^a   Patil, N ^d   Maniak, P J ^d   Iijima, K ^a   Kita, H ^a,c   O'Grady, S M ^d  

^a MAYO CLINIC   (United States)

^b SAGA UNIVERSITY   (Japan)

^c MAYO GRADUATE SCHOOL   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

airway epithelial cells; asthma; IL 33; lung; nuclear factor erythroid 2 related factor 2; reactive oxygen species

Indexed keywords

ACETYLCYSTEINE; ADENOSINE TRIPHOSPHATE; ALDEHYDE OXIDASE; ALDEHYDE OXIDASE 1; BARDOXOLONE METHYL; CALCIUM; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE; GLUTATHIONE TRANSFERASE P1; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 1A; INTERLEUKIN 13; INTERLEUKIN 33; INTERLEUKIN 5; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SULFIREDOXIN 1; THIOREDOXIN 1; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; ALLERGEN; ANTIOXIDANT; METHYL 2-CYANO-3,12-DIOXOOLEAN-1,9-DIEN-28-OATE; OLEANOLIC ACID;

AIRWAY EPITHELIUM CELL; ALTERNARIA ALTERNATA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPERGILLUS FUMIGATUS; ASTHMA; BRONCHIAL CELL LINE; CALCIUM CELL LEVEL; CELL NUCLEUS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOPLASM; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT INFLAMMATION; ANALOGS AND DERIVATIVES; ANIMAL; DRUG EFFECT; EPITHELIUM CELL; IMMUNOLOGY; KNOCKOUT MOUSE; LUNG; METABOLISM; RESPIRATORY MUCOSA;

ADENOSINE TRIPHOSPHATE; ALLERGENS; ANIMALS; ANTIOXIDANTS; CALCIUM; EPITHELIAL CELLS; FEMALE; HUMANS; INTERLEUKIN-33; LUNG; MICE; MICE, KNOCKOUT; NF-E2-RELATED FACTOR 2; OLEANOLIC ACID; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RESPIRATORY MUCOSA;

EID: 85017372490     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.13158     Document Type: Article

References (43)

1. Eder W, Ege MJ, von Mutius E. The asthma epidemic. N Engl J Med 2006;355:2226-2235.
2. Holgate ST. Pathophysiology of asthma: what has our current understanding taught us about new therapeutic approaches? J Allergy Clin Immunol 2011;128:495-505.
3. Ray A, Raundhal M, Oriss TB, Ray P, Wenzel SE. Current concepts of severe asthma. J Clin Invest 2016;126:2394-2403.
4. Olin JT, Wechsler ME. Asthma: pathogenesis and novel drugs for treatment. BMJ 2014;349:g5517.
5. Paul WE, Zhu J. How are T(H)2-type immune responses initiated and amplified? Nat Rev Immunol 2010;10:225-235.
6. Moussion C, Ortega N, Girard JP. The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel ‘alarmin’? PLoS One 2008;3:e3331.
7. Bessa J, Meyer CA, de Vera Mudry MC, et al. Altered subcellular localization of IL-33 leads to non-resolving lethal inflammation. J Autoimmun 2014;55:33-41.
8. Molofsky AB, Savage AK, Locksley RM. Interleukin-33 in tissue homeostasis, Injury, and Inflammation. Immunity 2015;42:1005-1019.
9. Lloyd CM, Saglani S. Epithelial cytokines and pulmonary allergic inflammation. Curr Opin Immunol 2015;34:52-58.
10. Liew FY, Girard JP, Turnquist HR. Interleukin-33 in health and disease. Nat Rev Immunol 2016;16:676-689.
11. Nathan C, Cunningham-Bussel A. Beyond oxidative stress: an immunologist's guide to reactive oxygen species. Nat Rev Immunol 2013;13:349-361.
12. Comhair SA, Erzurum SC. Redox control of asthma: molecular mechanisms and therapeutic opportunities. Antioxid Redox Sign 2010;12:93-124.
13. Moreno-Macias H, Romieu I. Effects of antioxidant supplements and nutrients on patients with asthma and allergies. J Allergy Clin Immunol 2014;133:1237-1244.
14. Lee JM, Calkins MJ, Chan K, Kan YW, Johnson JA. Identification of the NF-E2-related factor-2-dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide microarray analysis. J Biol Chem 2003;278:12029-12038.
15. Ma Q. Role of nrf2 in oxidative stress and toxicity. Annu Rev Pharmacol Toxicol 2013;53:401-426.
16. Al-Sawaf O, Clarner T, Fragoulis A, et al. Nrf2 in health and disease: current and future clinical implications. Clin Sci 2015;129:989-999.
17. Howden R. Nrf2 and cardiovascular defense. Oxid Med Cell Long 2013;2013:104308.
18. Tan SM, de Haan JB. Combating oxidative stress in diabetic complications with Nrf2 activators: how much is too much? Radox Res 2014;19:107-117.
19. Townsend MJ, Fallon PG, Matthews DJ, Jolin HE, McKenzie AN. T1/ST2-deficient mice demonstrate the importance of T1/ST2 in developing primary T helper cell type 2 responses. J Exp Med 2000;191:1069-1076.
20. Bush RK, Prochnau JJ. Alternaria-induced asthma. J Allergy Clin Immunol 2004;113:227-234.
21. Denning DW, O'Driscoll BR, Hogaboam CM, Bowyer P, Niven RM. The link between fungi and severe asthma: a summary of the evidence. Eur Respir J 2006;27:615-626.
22. Kouzaki H, Iijima K, Kobayashi T, O'Grady SM, Kita H. The danger signal, extracellular ATP, is a sensor for an airborne allergen and triggers IL-33 release and innate Th2-type responses. J Immunol 2011;186:4375-4387.
23. Kakkar R, Hei H, Dobner S, Lee RT. Interleukin 33 as a mechanically responsive cytokine secreted by living cells. J Biol Chem 2012;287:6941-6948.
24. Hristova M, Habibovic A, Veith C, et al. Airway epithelial dual oxidase 1 mediates allergen-induced IL-33 secretion and activation of type 2 immune responses. J Allergy Clin Immunol 2016;137:1545-1556.
25. O'Grady SM, Patil N, Melkamu T, Maniak PJ, Lancto C, Kita H. ATP release and Ca2+ signalling by human bronchial epithelial cells following Alternaria aeroallergen exposure. J Physiol 2013;591:4595-4609.
26. Li Y, Trush MA. Diphenyleneiodonium, an NAD(P)H oxidase inhibitor, also potently inhibits mitochondrial reactive oxygen species production. Biochem Biophys Res Commun 1998;253:295-299.
27. Byers DE, Alexander-Brett J, Patel AC, et al. Long-term IL-33-producing epithelial progenitor cells in chronic obstructive lung disease. J Clin Invest 2013;123:3967-3982.
28. Gorrini C, Harris IS, Mak TW. Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Disc 2013;12:931-947.
29. Kode A, Rajendrasozhan S, Caito S, Yang SR, Megson IL, Rahman I. Resveratrol induces glutathione synthesis by activation of Nrf2 and protects against cigarette smoke-mediated oxidative stress in human lung epithelial cells. Am J Physiol Lung Cell Mol Physiol 2008;294:L478-L488.
30. de Zeeuw D, Akizawa T, Audhya P, et al. Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease. N Engl J Med 2013;369:2492-2503.
31. Nair AB, Jacob S. A simple practice guideline for dose conversion between animals and human. J Basic Clin Pharmacol 2016;7:27-31.
32. Wang YY, Yang YX, Zhe H, He ZX, Zhou SF. Bardoxolone methyl (CDDO-Me) as a therapeutic agent: an update on its pharmacokinetic and pharmacodynamic properties. Drug Design Develop Ther 2014;8:2075-2088.
33. Brookes PS, Yoon Y, Robotham JL, Anders MW, Sheu SS. Calcium, ATP, and ROS: a mitochondrial love-hate triangle. Am J Physiol Cell Physiol 2004;287:C817-C833.
34. Yu H, Yang J, Zhou X, Xiao Q, Lu Y, Xia L. High glucose induces dysfunction of airway epithelial barrier through down-regulation of connexin 43. Exp Cell Res 2016;342:11-19.
35. Krick S, Wang J, St-Pierre M, Gonzalez C, Dahl G, Salathe M. Dual Oxidase 2 (Duox2) Regulates Pannexin 1-mediated ATP release in primary human airway epithelial cells via changes in intracellular pH and not H2O2 production. J Biol Chem 2016;291:6423-6432.
36. Batra N, Riquelme MA, Burra S, Kar R, Gu S, Jiang JX. Direct regulation of osteocytic connexin 43 hemichannels through AKT kinase activated by mechanical stimulation. J Biol Chem 2014;289:10582-10591.
37. Kinnula VL. Focus on antioxidant enzymes and antioxidant strategies in smoking related airway diseases. Thorax 2005;60:693-700.
38. Walsh J, Jenkins RE, Wong M, et al. Identification and quantification of the basal and inducible Nrf2-dependent proteomes in mouse liver: biochemical, pharmacological and toxicological implications. J Proteomics 2014;108:171-187.
39. Liby KT, Sporn MB. Synthetic oleanane triterpenoids: multifunctional drugs with a broad range of applications for prevention and treatment of chronic disease. Pharmacol Rev 2012;64:972-1003.
40. Sussan TE, Gajghate S, Chatterjee S, et al. Nrf2 reduces allergic asthma in mice through enhanced airway epithelial cytoprotective function. Am J Physiol Lung Cell Mol Physiol 2015;309:L27-L36.
41. Boyman O, Kaegi C, Akdis M, et al. EAACI IG Biologicals task force paper on the use of biologic agents in allergic disorders. Allergy 2015;70:727-754.
42. Comhair SA, Bhathena PR, Dweik RA, Kavuru M, Erzurum SC. Rapid loss of superoxide dismutase activity during antigen-induced asthmatic response. Lancet 2000;355:624.
43. Peterson JD, Herzenberg LA, Vasquez K, Waltenbaugh C. Glutathione levels in antigen-presenting cells modulate Th1 versus Th2 response patterns. Proc Natl Acad Sci USA 1998;95:3071-3076.